Retrospective, real-life study of venetoclax plus azacitidine or low-dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy.
Cancer Med
; 12(6): 7175-7181, 2023 03.
Article
in En
| MEDLINE
| ID: mdl-36482507
Full text:
1
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Cytarabine
Type of study:
Guideline
Limits:
Humans
Language:
En
Journal:
Cancer Med
Year:
2023
Type:
Article
Affiliation country:
France